The House narrowly passed a budget reconciliation bill, including billions of dollars in tax cuts for the wealthy along with billions of dollars in cuts to health program spending. But the Senate is expected to make major changes to the measure before it can go to President Donald Trump for his signature. This week’s panelists are Julie Rovner of KFF Health News, Anna Edney of Bloomberg News, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico.
The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.
A GOP tax-and-spending bill the House approved Thursday would slash federal Medicaid reimbursement for states that offer health coverage to immigrants without legal status.
As St. Louis deals with more than $1.6 billion in estimated property damage from the May 16 tornado, locals are pouring in to help the hard-hit area of North St. Louis. It’s unclear if residents can count on federal support as they rebuild.
Artificial intelligence products with lifelike voices are being marketed to schedule or cancel medical visits, refill prescriptions, and help triage patients. Soon, many patients might initiate contact with the health system by speaking not with a human but with AI.
President Donald Trump’s budget office says he’ll continue to fund the new 988 suicide prevention hotline, but documents sent to Congress offer clues — amid some mixed messages — about the administration’s approach to two pressing public health issues: mental health and addiction.
Late last year, South Carolina Medicaid approved a class of medications known as GLP-1s to treat obesity, placing it among the few state programs covering these effective but expensive drugs. But access remains limited, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.
One thing experts agree on: The damage from the funding cuts will be varied and immense.
According to the timeline in the May 12 executive order, prescription drug price reductions would not happen “almost immediately,” but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.
Fresh studies expose a gap in the FDA’s assessments of foods: Widely used additives could damage the mix of bacteria in your gut, causing health problems.
